Zobrazeno 1 - 10
of 31
pro vyhledávání: '"паклитаксел"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 4-21 (2020)
Objective. To determine the pharmacoeconomical feasibility of using a combination of atezolizumab + nab-paclitaxel in the 1st line of therapy for locally advanced or metastatic triple negative breast cancer (TNBC) in adult PDL1 positive patients in t
Externí odkaz:
https://doaj.org/article/547b6835489f46afa9c36e6ec461c397
Autor:
I. F. Gareev, O. A. Beylerli, V. N. Pavlov, Shiguang Zhao, Xin Chen, Zhixing Zheng, Chen Shen, Jinxian Sun
Publikováno v:
Креативная хирургия и онкология, Vol 9, Iss 1, Pp 66-74 (2019)
Glial tumors, and in particular anaplastic astrocytomas and glioblastoma multiforme (GBM), are aggressive brain tumors with poor prognosis and high recurrence rates. Current treatment strategies are based on open surgery, chemotherapy and radiation t
Externí odkaz:
https://doaj.org/article/b2ea6d1297664bdb9c3a2b166a9a1736
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1 (2020)
Данный выпуск журнала «Качественная клиническая практика» посвящён нескольким научным направлениям изучения лекарственных препарато
Externí odkaz:
https://doaj.org/article/b02d92c07b504fb485e7824944fdc82b
Autor:
V.M. Kopchak, I.I. Zaivelieva
Publikováno v:
Практична онкологія-Praktična onkologìâ; Том 3, № 1 (2020); 42-45
Practical oncology; Том 3, № 1 (2020); 42-45
Практическая онкология-Praktična onkologìâ; Том 3, № 1 (2020); 42-45
Practical oncology; Том 3, № 1 (2020); 42-45
Практическая онкология-Praktična onkologìâ; Том 3, № 1 (2020); 42-45
Pancreatic cancer is a malignant tumor that has a high metastasis potential and restrained sensitivity to chemotherapeutic treatment, characterized by a relatively poor prognosis for patients to recover, especially with diffused and unresectable form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a9915ca9d0dd75638eb6d38919ece9
https://doi.org/10.22141/2663-3272.3.1.2020.209824
https://doi.org/10.22141/2663-3272.3.1.2020.209824
Autor:
T. G. Borovskaya, V. A. Grigor’eva, Yu. A. Shchemerova, S. I. Kamalova, A. V. Vychuzhanina, N. A. Krivova, O. B. Zaeva, V. E. Goldberg, A. M. Dygai
Publikováno v:
Bulletin of experimental biology and medicine. 2022. Vol. 172, № 5. P. 632-636
The regenerative properties of p-tyrosol were investigated in a model of testicular insufficiency caused by a toxic effect on spermatogonial stem cells (single administration of paclitaxel in the maximum tolerable dose). Against the background of p-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a828463ed457b77f988355f5bec3d2d4
https://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001002445
https://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001002445
Publikováno v:
ScienceRise: Medical Science; № 3(42) (2021); 20-26
ScienceRise: Medical Science; No. 3(42) (2021); 20-26
ScienceRise: Medical Science; No. 3(42) (2021); 20-26
Paclitaxel is an effective chemotherapeutic agent for many cancers, but it has a number of limiting side effects that not only significantly reduce the quality of life of patients, but also limit their further treatment. Peripheral neuropathy is one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::a8e8da80c025c2ab19b602ac75dfee5c
http://journals.uran.ua/sr_med/article/view/232975
http://journals.uran.ua/sr_med/article/view/232975
Publikováno v:
Morphologia; Том 15 № 2 (2021); 31-38
Morphologia; Vol. 15 No. 2 (2021); 31-38
Morphologia; Vol. 15 No. 2 (2021); 31-38
Background. Paclitaxel-induced peripheral neuropathy (PIPN) is a major side effect of paclitaxel in patients with cancer with no fully known mechanisms. The aim of the study was to investigate the fine sub-microscopic structure of the spinal cord ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::7a810fde1b5a1179daadc5c2c6256fc1
http://morphology.dma.dp.ua/article/view/241645
http://morphology.dma.dp.ua/article/view/241645
Autor:
A A Tryakin, S A Tyulyandin, M Yu Fedyanin, Yu S Sergeev, I A Faynshteyn, B E Polotskiy, K M Figurin, T I Zakharova, A M Garin
Publikováno v:
Современная онкология, Vol 10, Iss 2, Pp 67-71 (2008)
Несмотря на очевидные успехи современной химиотерапии при лечении метастатических несеминомных герминогенных опухолей (ГО), возможно
Externí odkaz:
https://doaj.org/article/75cec88a0a1c46daa5c9a57a0ec30d65
Publikováno v:
Современная онкология, Vol 10, Iss 1, Pp 57-60 (2008)
Externí odkaz:
https://doaj.org/article/fc107d025e11437f8f77e2fe3351c049
Publikováno v:
Медицина болю, Vol 4, Iss 2, Pp 41-52 (2019)
Medicina bolu; Том 4 № 2 (2019): Pain medicine; 41-52
Pain medicine; Vol 4 No 2 (2019): Pain medicine; 41-52
Medicina bolu; Том 4 № 2 (2019): Pain medicine; 41-52
Pain medicine; Vol 4 No 2 (2019): Pain medicine; 41-52
This study is aimed to compare the difference of neutropenia with peripheral neuropathy condition, after administration of 3 hours and 24 hours Paclitaxel infusion in adjuvant therapy with PaclitaxelCarboplatin toward patient with ovarian carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1857bed9a94bb35a89aaf5f74f9ef7d
https://painmedicine.org.ua/index.php/pnmdcn/article/view/197
https://painmedicine.org.ua/index.php/pnmdcn/article/view/197